211 top medical experts on Kernicterus across 28 countries and 21 U.S. states, including 64 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Kernicterus: A term used pathologically to describe bilirubin staining of the basal ganglia; brain stem; and cerebellum and clinically to describe a syndrome associated with hyperbilirubinemia. Clinical features include athetosis, muscle spasticity or hypotonia, impaired vertical gaze, and deafness. Nonconjugated bilirubin enters the brain and acts as a neurotoxin, often in association with conditions that impair the blood-brain barrier (e.g., sepsis). This condition occurs primarily in neonates (infant, newborn), but may rarely occur in adults. (Menkes, Textbook of Child Neurology, 5th ed, p613)
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Hyperbilirubinemia (2,722), Fetal Erythroblastosis (1,191), Metabolic Brain Diseases (2,299).
  4. Clinical Trials ClinicalTrials.gov : at least 7 including 3 Completed, 3 Recruiting
  5. Synonyms: Bilirubin Encephalopathy,  Hyperbilirubinemic Encephalopathy


  

        

                    


    Computing Expert Listing ...

);